• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.
    ​​​​​​​​​​​​​​​​​​​​​​​​>PDMP Laws and Regulations
    >OCSA Laws and Regulations

    OCSA Update

    Post Card re Online Registration 
     Effective December 31, 2020, OCSA will no longer be accepting paper CDS applications for a new registration and renewal registration within the current renewal period.   Please go to the OCSA online website at https://egov.maryland.gov/mdh/cds to register or renew a controlled dangerous substances registration.

    OCSA is accepting paper CDS applications for an address change, name change, change of ownership, replacement/duplicate copy of CDS certificate, and expired renewal registration.  Please visit the OCSA website​ to download the CDS applicationfor those functions. Please submit the CDS application to the Office of Controlled Substances Administration, 1223 W. Pratt Street, Baltimore, MD, 21223.


    ​O​ffice of Provider Engagement and Regulation​

    The mission of the Office of Provider Engagement and Regulation (OPER) is to provide a 
    center of support for prescribers and dispensers to better promote professional education, informed clinical decision-making, best practices and innovation so that 
    Maryland patients experience optimal access, efficacy and safety in connection
    with controlled substances.   

    OPER was formed February 2019 and consists of the Office of Controlled Substances Administration (OCSA) and the Prescription Drug Monitoring Program (PDMP).
    The OCSA and the PDMP continue to prioritize all existing directives, and OPER 
    maintains all mandated requirements and restrictions related to data access.  
    For more information on the OCSA and PDMP, please click the links below 
    to the program websites.

     Webpage Links

    PDMP ​Operations Manager - Sara Roberson, MSW
    OCSA Operations Manager - Sandra Yankosky​​